search
Back to results

Efficacy of a Very Low Calories Ketogenic Diet in Obese Patients With Fibromyalgia or Symptomatic Knee Osteoarthritis (KD-FM-OA)

Primary Purpose

Fibromyalgia, Knee Osteoarthritis

Status
Recruiting
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Very low-calorie ketogenic diet for patients with symptomatic knee osteoarthritis
Very low-calorie ketogenic diet for patients with fibromyalgia
Sponsored by
Istituto Ortopedico Rizzoli
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Fibromyalgia

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Age > 18 years and < 65 years Body mass index ≥ 30 kg/m2 Failed to achieve weight loss with standard low-calories diet Any of the following conditions: BMI ≥ 35 kg/m2 Past diagnosis of type 2 diabetes without β-cell failure Hypertriglyceridemia (fasting triglycerides ≥ 150 mg/dL) or taking lipid-lowering medications Hypercholesterolemia (total cholesterol > 200 mg/dL) or taking lipid-lowering medications Past diagnosis of arterial hypertension or taking blood pressure-lowering medications Past diagnosis of non-alcoholic fatty liver disease Past diagnosis of heart failure class NYHA I-II Past history of myocardial infarction (> 12 months), stroke/minor stroke (> 12 months) Past diagnosis of carotid atherosclerosis Past diagnosis of polycystic ovary syndrome (PCOS) Past diagnosis of neurodegenerative disorders Fibromyalgia classified according to 2016 Revisions to the 2010/2011 European League Against Rheumatism/ American College of Rheumatology OR Symptomatic knee osteoarthritis Exclusion Criteria: Age < 18 or > 65 years Currently pregnant or breastfeeding Past diagnosis of type 1 diabetes mellitus, latent autoimmune diabetes in adults, β-cell failure in type 2 diabetes mellitus, use of sodium/glucose cotransporter 2 inhibitors (risk for euglycemic diabetic ketoacidosis) Past diagnosis of kidney failure and moderate-to-severe chronic kidney disease, liver failure, hearth failure NYHA III-IV, respiratory failure Past diagnosis of unstable angina Recent stroke or myocardial infarction (< 12 months) Cardiac arrhythmias Past diagnosis of eating disorders and other severe mental illnesses, alcohol and substance abuse Active/severe infections 48 h prior to elective surgery or invasive procedures and perioperative period Past diagnosis of rare disorders: porphyria, carnitine deficiency, carnitine palmitoyltransferase deficiency, carnitine-acylcarnitine translocase deficiency, mitochondrial fatty acid β-oxidation disorders, pyruvate carboxylase deficiency Allergy to protein-preparations ingredients Past or current history of gallstones

Sites / Locations

  • IRCCS istituto Ortopedico RizzoliRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Other

Arm Label

Symptomatic knee osteoarthritis

obese patients with fibromyalgia

Arm Description

obese patients with symptomatic knee osteoarthritis eligible to a very low calories ketogenic diet

obese patients with with fibromyalgia eligible to a very low calories ketogenic diet

Outcomes

Primary Outcome Measures

efficacy of the very low-calorie ketogenic diet in patient with fibromyalgia
change in Fibromyalgia Impact Questionnaire total score for fibromyalgia
efficacy of the very low-calorie ketogenic diet in patient with osteoarthritis
change in Western Ontario total score for osteoarthritis

Secondary Outcome Measures

Full Information

First Posted
April 13, 2023
Last Updated
April 27, 2023
Sponsor
Istituto Ortopedico Rizzoli
search

1. Study Identification

Unique Protocol Identification Number
NCT05848544
Brief Title
Efficacy of a Very Low Calories Ketogenic Diet in Obese Patients With Fibromyalgia or Symptomatic Knee Osteoarthritis
Acronym
KD-FM-OA
Official Title
Efficacy of a Very Low Calories Ketogenic Diet in Obese Patients With Fibromyalgia or Symptomatic Knee Osteoarthritis
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Recruiting
Study Start Date
April 2, 2021 (Actual)
Primary Completion Date
December 31, 2023 (Anticipated)
Study Completion Date
December 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Istituto Ortopedico Rizzoli

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Adult patients with fibromyalgia or symptomatic knee osteoarthritis and comorbid obesity eligible to a very low calories ketogenic diet will be enrolled in the pilot study
Detailed Description
the study will be conducted following different periods: Free diet (for 4 weeks). After recruitment, the patient will enter "free diet phase" in which he/she will be asked to follow a normal free diet for 4 weeks. During this period, a nutritional interview will be carried out by a trained dietician who will elaborate a personalized diet and order the ketogenic products on the basis of patient's preferences. very low calories ketogenic diet (for 8 weeks). After the free diet period, the patient will start the very low calories ketogenic regimen. At the beginning of this period a box with the commercial products necessary to cover the whole study period will be hand-delivered by a dietician that will instruct the patient on the correct use and storage. Maintenance (for 12 weeks). After very low calories ketogenic diet phase, the patient will start maintenance period as described

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fibromyalgia, Knee Osteoarthritis

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Symptomatic knee osteoarthritis
Arm Type
Other
Arm Description
obese patients with symptomatic knee osteoarthritis eligible to a very low calories ketogenic diet
Arm Title
obese patients with fibromyalgia
Arm Type
Other
Arm Description
obese patients with with fibromyalgia eligible to a very low calories ketogenic diet
Intervention Type
Dietary Supplement
Intervention Name(s)
Very low-calorie ketogenic diet for patients with symptomatic knee osteoarthritis
Intervention Description
A personalized very low-calorie ketogenic diet will be prepared for each patient by specialized dietitians using a combination of commercially-available ketogenic preparations and patient's handmade prepared meals
Intervention Type
Dietary Supplement
Intervention Name(s)
Very low-calorie ketogenic diet for patients with fibromyalgia
Intervention Description
A personalized very low-calorie ketogenic diet will be prepared for each patient by specialized dietitians using a combination of commercially-available ketogenic preparations and patient's handmade prepared meals
Primary Outcome Measure Information:
Title
efficacy of the very low-calorie ketogenic diet in patient with fibromyalgia
Description
change in Fibromyalgia Impact Questionnaire total score for fibromyalgia
Time Frame
baseline, 8 weeks and 20 weeks
Title
efficacy of the very low-calorie ketogenic diet in patient with osteoarthritis
Description
change in Western Ontario total score for osteoarthritis
Time Frame
baseline, 8 weeks and 20 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age > 18 years and < 65 years Body mass index ≥ 30 kg/m2 Failed to achieve weight loss with standard low-calories diet Any of the following conditions: BMI ≥ 35 kg/m2 Past diagnosis of type 2 diabetes without β-cell failure Hypertriglyceridemia (fasting triglycerides ≥ 150 mg/dL) or taking lipid-lowering medications Hypercholesterolemia (total cholesterol > 200 mg/dL) or taking lipid-lowering medications Past diagnosis of arterial hypertension or taking blood pressure-lowering medications Past diagnosis of non-alcoholic fatty liver disease Past diagnosis of heart failure class NYHA I-II Past history of myocardial infarction (> 12 months), stroke/minor stroke (> 12 months) Past diagnosis of carotid atherosclerosis Past diagnosis of polycystic ovary syndrome (PCOS) Past diagnosis of neurodegenerative disorders Fibromyalgia classified according to 2016 Revisions to the 2010/2011 European League Against Rheumatism/ American College of Rheumatology OR Symptomatic knee osteoarthritis Exclusion Criteria: Age < 18 or > 65 years Currently pregnant or breastfeeding Past diagnosis of type 1 diabetes mellitus, latent autoimmune diabetes in adults, β-cell failure in type 2 diabetes mellitus, use of sodium/glucose cotransporter 2 inhibitors (risk for euglycemic diabetic ketoacidosis) Past diagnosis of kidney failure and moderate-to-severe chronic kidney disease, liver failure, hearth failure NYHA III-IV, respiratory failure Past diagnosis of unstable angina Recent stroke or myocardial infarction (< 12 months) Cardiac arrhythmias Past diagnosis of eating disorders and other severe mental illnesses, alcohol and substance abuse Active/severe infections 48 h prior to elective surgery or invasive procedures and perioperative period Past diagnosis of rare disorders: porphyria, carnitine deficiency, carnitine palmitoyltransferase deficiency, carnitine-acylcarnitine translocase deficiency, mitochondrial fatty acid β-oxidation disorders, pyruvate carboxylase deficiency Allergy to protein-preparations ingredients Past or current history of gallstones
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Francesco Ursini, MD
Phone
0039051.63.66
Ext
386
Email
francesco.ursini@ior.it
First Name & Middle Initial & Last Name or Official Title & Degree
Jacopo Ciaffi, MD
Email
jacopo.ciaffi@ior.it
Facility Information:
Facility Name
IRCCS istituto Ortopedico Rizzoli
City
Bologna
ZIP/Postal Code
40136
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Francesco Ursini, MD
Phone
0039051.63.66
Ext
386
Email
francesco.ursini@ior.it

12. IPD Sharing Statement

Learn more about this trial

Efficacy of a Very Low Calories Ketogenic Diet in Obese Patients With Fibromyalgia or Symptomatic Knee Osteoarthritis

We'll reach out to this number within 24 hrs